EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Algor‐Ethics in Diabetes Care: Mapping the Route

Joshua Bemporad iD, Francesco De Domenico iD, Paolo Pozzilli

Diabetes/Metabolism Research and Reviews · 2026-02 · 42 (2)

DOI: 10.1002/dmrr.70139 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 18.02.2026. Verfasst von Joshua Bemporad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Campus Bio-Medico University, Rome, Italy. Hauptthemen laut MEDLINE: Artificial Intelligence, Diabetes Mellitus, Algorithms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus represents a multifaceted global health challenge, frequently coexisting with obesity, cardiovascular complications, and metabolic disorders. Effective management requires individualised, evidence‐based decisions informed by an array of clinical, genetic, and lifestyle data. With the rapid growth of digital health technologies, artificial intelligence (AI) and algorithmic systems have emerged as powerful tools to support clinicians in diagnosis, treatment planning, and risk stratification. While AI shows promise in improving diabetes outcomes and health system efficiency, its integration into patient care is not without ethical and epistemic challenges. Algorithmic decision‐making can influence therapeutic strategies, sometimes without full transparency or adequate oversight, potentially compromising human values such as autonomy, justice, and trust. In this context, the discipline of ‘Algor‐ethics’, a term coined to describe the intersection of algorithmic systems and ethical principles, becomes critical. This article explores the foundational concepts of Algor‐ethics applied to diabetes care, analyzes the current state of AI integration, and highlights the epistemic and ethical implications of algorithmic decision‐making. Emphasis is placed on developing a framework that ensures AI is implemented safely, equitably, and responsibly, particularly for complex patients with diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceDiabetes MellitusAlgorithmsHumansDigital Health

Stichwörter der Autor:innen

Algor‐ethicsalgorethicsartificial intelligencediabetesdiabetes careethicsmachine learning

Autor:innen und Institutionen

  • Campus Bio-Medico University, Rome, Italy.
  • Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Blizard Institute, Centre of Immunobiology, Barts and the London School of Medicine, Queen Mary, University of London, London, UK.

ORCID-Profile: Joshua Bemporad, Francesco De Domenico

Zitieren

APA

Bemporad, J., De Domenico, F., & Pozzilli, P. (2026). Algor‐Ethics in Diabetes Care: Mapping the Route. Diabetes/Metabolism Research and Reviews, 42(2). https://doi.org/10.1002/dmrr.70139

Vancouver

Bemporad J, De Domenico F, Pozzilli P. Algor‐Ethics in Diabetes Care: Mapping the Route. Diabetes/Metabolism Research and Reviews. 2026;42(2). doi:10.1002/dmrr.70139

BibTeX
@article{Bemporad2026,
  author = {Bemporad, Joshua and De Domenico, Francesco and Pozzilli, Paolo},
  title = {Algor‐Ethics in Diabetes Care: Mapping the Route},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2026},
  volume = {42},
  number = {2},
  doi = {10.1002/dmrr.70139}
}
Kostenlos starten →